News
TMO
573.55
+0.32%
1.82
Validea Detailed Fundamental Analysis - TMO
NASDAQ · 7h ago
Thermo Fisher Scientific First Quarter 2024 Earnings: Beats Expectations
Thermo Fisher Scientific's revenue exceeded analyst estimates by 1.7%. The company's shares are up 5.6% from a week ago. Revenue is forecast to grow 5.8% in the next 3 years. The company has identified one warning sign with the company.
Simply Wall St · 10h ago
Weitz Large Cap Equity Fund Q1 2024 Commentary
Weitz Large Cap Equity Fund's Institutional Class returned +7.79% for the first quarter compared to +10.30% for Russell 1000 Index. Fund returns have now topped 50% from the October 2022 lows. Meta Platforms, Alphabet, Amazon and Charter Communications were the Fund's leading quarterly contributors.
Seeking Alpha · 11h ago
Thermo Fisher Outperforms in Q1 with Strong Revenue and Earnings Growth, Justifying Buy Rating
TipRanks · 15h ago
Thermo Fisher Price Target Raised to $615.00/Share From $590.00 by Barclays
Dow Jones · 1d ago
Thermo Fisher Is Maintained at Equal-Weight by Barclays
Dow Jones · 1d ago
Barclays Maintains Equal-Weight on Thermo Fisher Scientific, Raises Price Target to $615
Benzinga · 1d ago
Thermo Fisher Is Maintained at Buy by Deutsche Bank
Dow Jones · 1d ago
Thermo Fisher Price Target Raised to $610.00/Share From $600.00 by Deutsche Bank
Dow Jones · 1d ago
Deutsche Bank Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $610
Benzinga · 1d ago
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings
Thermo Fisher Scientific Inc. Reported better-than-expected first-quarter revenue and raised its FY24 guidance on Wednesday. The company posted a revenue of $10.34 billion, down 3% year over year. Thermo Fisher's shares rose 0.5% to close at $577.39.
Benzinga · 1d ago
Thermo Fisher Is Maintained at Overweight by JP Morgan
Dow Jones · 1d ago
Thermo Fisher Price Target Raised to $650.00/Share From $600.00 by JP Morgan
Dow Jones · 1d ago
THERMO FISHER SCIENTIFIC <TMO.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $610 FROM $600
Reuters · 1d ago
JP Morgan Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650
Benzinga · 1d ago
7 Analysts Assess Thermo Fisher Scientific: What You Need To Know
Analysts' ratings for Thermo Fisher Scientific over the last quarter vary from bullish to bearish. The company has an average 12-month price target of $628.14. 7 analysts have upgraded their ratings for the company over the past quarter. The firm sells scientific instruments and laboratory equipment.
Benzinga · 1d ago
BUZZ-Street View: Thermo Fisher's 2024 'setup looks good'
Thermo Fisher beat Wall Street estimates for quarterly profit and raised annual profit forecast. China stimulus could be 'cherry on top' - JPM. Morgan Stanley says company's 2024 outlook seems 'conservative' - J.P. Morgan. Thermo Fisher expects annual adj. Profit of $21.14 to $22.02 per share.
Reuters · 1d ago
RBC Capital Remains a Buy on Thermo Fisher (TMO)
TipRanks · 1d ago
Thermo Fisher Price Target Cut to $620.00/Share From $621.00 by Baird
Dow Jones · 1d ago
Thermo Fisher Is Maintained at Outperform by Baird
Dow Jones · 1d ago
More
Webull provides a variety of real-time TMO stock news. You can receive the latest news about Thermo Fishr Sci through multiple platforms. This information may help you make smarter investment decisions.
About TMO
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.